Insider trade

Director sold ~$248K of AGX shares in the open market

Traded Apr 28, 2026 · Filed Apr 29, 2026

Why it stands out

A board member of Argan sold $248K of Argan shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

DirectorIndirect holding$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$248,456

Shares × reported transaction price

Timing vs results

33 days after results of Mar 26, 2026, 37 days before results of Jun 4, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+3.0%	+1.8%	+1.2%
30 days	−3.5%	+5.5%	−9.0%
90 days	−26.5%	+1.5%	−28.0%

Past results only. Not a forecast.

On April 28, 2026, the Emily K. Leimkuhler Trust, of which the Reporting Person serves as Trustee, sold 400 shares of the Issuer's common stock in an open market transaction.

Director sold

5mo ago

A board member of Argan sold $1.89M of Argan shares. Nobody planned it ahead of time.

5mo ago

Gift or transfer — classified separately from trades.

Director sold

5mo ago

A board member of Argan sold $221K of Argan shares. Nobody planned it ahead of time.